-
Mashup Score: 0Pharmalittle: FDA finds ‘potential systemic bias’ in Amgen cancer drug trial; drugmakers organize to push back on antitrust reviews - 7 month(s) ago
A study of Amgen’s Lumakris may reflect systemic biases, the FDA said ahead of a meeting to determine whether the drug should stay on the market.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1South Africa investigates Johnson & Johnson over 'excessive pricing' for its TB drug - 7 month(s) ago
South African authorities are investigating Johnson & Johnson and its Janssen subsidiary over “excessive pricing” of a lifesaving tuberculosis drug.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Alzheimer's diagnosis revamp embraces rating scale similar to cancer; FTC seeks info on Pfizer-Seagen deal - 9 month(s) ago
Alzheimer’s experts are devising a seven-point rating scale based on cognitive and biological changes to diagnose the disorder.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: EU fines Illumina $475M for closing Grail deal; life-threatening lead poisoning antidote in short supply - 9 month(s) ago
Supplies are running out for dimercaprol, a key antidote for life-threatening lead poisoning.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high - 10 month(s) ago
The case turned on claims that a deal Gilead and Teva reached to end patent litigation between the two companies was illegal.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high - 11 month(s) ago
“We’ve lost an opportunity to have direct government purchases of hundreds of thousands of doses of generic Truvada at a lower cost to dramatically lower HIV infections,” said Peter Staley of PrEP4All.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 4FTC move to block the Amgen-Horizon deal highlights concerns over negotiations with insurers - 11 month(s) ago
The FTC’s move to block the Amgen-Horizon deal highlights concerns over negotiations with insurers — and in particular, a practice known as bundling.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price negotiations - 1 year(s) ago
Congressional Republicans are scrambling to bar use of a quality-of-life metric, a push Democrats argue could hobble Medicare drug-price negotiations.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3
The Ohio attorney general filed a lawsuit on Monday accusing three large pharmacy benefit managers of fixing prices on some drugs.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0French court hands Novartis and Roche another win in battle over antitrust allegations involving eye drug - 1 year(s) ago
A French appeals court has overturned a record fine levied three years ago against Novartis and Roche for allegedly engaging in anti-competitive practices.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
Pharmalot.. Pharmalittle.. Good Morning: FDA finds ‘potential systemic bias’ in Amgen cancer drug trial; Drugmakers organize to push back on antitrust reviews & More news.. https://t.co/5XRiER293D #pharma #HIV #patents #antitrust #vaccines #COVID19 $MRNA $GSK $TEVA $SNY $LLY $NVS